Update in diagnosis and management of interstitial lung disease-Reference-Cited by-同舟云学术

Update in diagnosis and management of interstitial lung disease

Published:2017-04 Issue:2 Volume:17 Page:146-153
ISSN:1470-2118
Container-title:Clinical Medicine
language:en
Short-container-title:Clin Med

Author:

Mikolasch Theresia A,Garthwaite Helen S,Porter Joanna C

Publisher

Royal College of Physicians

Subject

General Medicine

Reference28 articles.

1. British Lung Foundation . Lung disease in the UK – big picture statistics. https://statistics.blf.org.uk/lung-disease-uk-big-picture [Accessed 19 October 2016].

2. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK

3. Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis

4. Cyclophosphamide versus Placebo in Scleroderma Lung Disease

5. Rituximab in severe, treatment-refractory interstitial lung disease

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic prediction of the causal relationship between systemic lupus erythematosus and interstitial lung disease: a two-sample Mendelian randomized study;2024-07-19

2. Optimizing treatment administration strategies using negative mNGS results in corticosteroid-sensitive diffuse parenchymal lung diseases;iScience;2024-07

3. Improving Accessibility to Patients with Interstitial Lung Disease (ILD): Barriers to Early Diagnosis and Timely Treatment in Latin America;International Journal of Environmental Research and Public Health;2024-05-19

4. Interstitial lung disease: a review of classification, etiology, epidemiology, clinical diagnosis, pharmacological and non-pharmacological treatment;Frontiers in Medicine;2024-04-18

5. A Machine Learning System to Indicate Diagnosis of Idiopathic Pulmonary Fibrosis Non-Invasively in Challenging Cases;Diagnostics;2024-04-17